Home » Topics » BioWorld Science

BioWorld Science
RSS

Ingenew BioPharma synthesizes new IL-1beta, IL-6 and TNF-alpha release inhibitors

May 4, 2022

Leukos Biotech patents serotonin 5-HT1B receptor antagonists

May 4, 2022

PRISM BioLab discovers Notch signaling inhibitors

May 4, 2022

New MRGPRX2 antagonists identified at GlaxoSmithKline

May 4, 2022

Storm Therapeutics divulges new METTL3 inhibitors

May 4, 2022

GTX-0196 shows complete tumor growth suppression in models of AML

May 4, 2022

Tripartite interactions between nervous system, immune cells and plaques drive atherosclerosis

May 3, 2022

Novel TRPC5 inhibitors show potential for the treatment of CKD

May 3, 2022

Ring Therapeutics describes in vitro system enabling human anellovirus production

May 3, 2022

ProfoundBio antibody-drug conjugate PRO-1102 shows potency in vitro and in vivo

May 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.